BECLIN 1 was initially isolated as an interactor of the oncogenic antiapoptotic protein BCL-2, and it was reported to be deleted in up to 75% of human ovarian cancers [9, 10]. This evidence concerns the gene BCL2 and ovarian carcinoma.